Compounds > tolvaptan
Page last updated: 2024-09-05

tolvaptan and Albuminuria

tolvaptan has been researched along with Albuminuria in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chapman, AB; Czerwiec, FS; Devuyst, O; Gansevoort, RT; Grantham, JJ; Higashihara, E; Krasa, HB; Meijer, E; Ouyang, J; Perrone, RD; Torres, VE1
Blais, JD; Chapman, AB; Czerwiec, FS; Devuyst, O; Gansevoort, RT; Grantham, JJ; Higashihara, E; Ouyang, J; Perrone, RD; Torres, VE1
Bae, KT; Chapman, AB; Czerwiec, FS; Devuyst, O; Gansevoort, RT; Grantham, JJ; Higashihara, E; Krasa, HB; Meijer, E; Ouyang, JJ; Perrone, RD; Torres, VE1

Trials

3 trial(s) available for tolvaptan and Albuminuria

ArticleYear
Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2016, Volume: 31, Issue:11

    Topics: Aged; Albuminuria; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Prospective Studies; Tolvaptan; Treatment Outcome

2016
Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial.
    Clinical journal of the American Society of Nephrology : CJASN, 2016, 05-06, Volume: 11, Issue:5

    Topics: Adult; Albuminuria; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Disease Progression; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hypernatremia; Hypertension; Kidney; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Pain; Polycystic Kidney, Autosomal Dominant; Severity of Illness Index; Tolvaptan

2016
Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2011, Volume: 57, Issue:5

    Topics: Adolescent; Adult; Albuminuria; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Disease Management; Double-Blind Method; Female; Humans; Male; Middle Aged; Pain; Polycystic Kidney, Autosomal Dominant; Prospective Studies; Receptors, Vasopressin; Tolvaptan; Treatment Outcome; Young Adult

2011